DoD

(redirected from Pin1)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

DOD

(communications)

DoD

(body)

DoD

(2)
Dial on Demand.

DOD

(1) (Dial On Demand) A feature that allows a device to automatically dial a telephone number. For example, an ISDN router with dial on demand will automatically dial up the ISP when it senses IP traffic destined for the Internet.

(2) (DoD) (Department Of Defense) The military branch of the U.S. government, which is under the direction of the Secretary of Defense, the primary defense policy adviser to the President. The Annual Report to the President and the Congress (Annual Defense Report) outlines the DoD's capabilities and plans.
References in periodicals archive ?
Pin1 regulates the timing of mammalian primordial germ cell proliferation.
The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.
As people get older and older, Pin1 levels drop, drop, drop," Lu says.
Boosting Pin1 levels may help untangle tau in people at risk of Alzheimer's disease, slowing the disease's progression or preventing it altogether.
In the July 31 Nature, Lu, Hunter, and their colleagues report that mice with an inactive Pin1 gene suffer nerve cell loss in the spinal cord and brain as the animals age.
The Pin1 enzyme, which has been linked to numerous human cancers, including prostate and breast cancer, may be one of the most prevalent tumor markers found to date.
It also means that the amount of Pin1 present in pre-therapy biopsies may allow doctors to counsel patients diagnosed with potential prostate cancer to wait and see, thereby avoiding or at least delaying surgery or radiation therapy.
It includes polyclonal and monoclonal antibodies, as well as methods for making antibodies to the Pin1 enzyme.
This Pin1 patent application complements our existing comprehensive intellectual property assets, which form the basis for a potentially wide array of new cancer therapies and diagnostics," said Pintex CEO George C.
Hillman said, "The discovery of the role of the Pin1 enzyme in human cancer creates a novel target with significant potential for creating new cancer therapeutics and reducing human suffering.
These funds will be used to continue preclinical development of Pin1 inhibitors and will move the company towards partnerships with pharmaceutical companies focused on oncology.